▎ TB-500 yog dab tsi?
TB-500 (Thymosin Beta-4) yog ib qho endogenous peptide tsim los ntawm 43 amino acids, muab tau los ntawm cov tub ntxhais ua haujlwm hauv cheeb tsam ntawm ib txwm tshwm sim tib neeg thymosin β4. Nws nthuav tawm cov dej solubility zoo heev thiab cov qauv kev ruaj ntseg, ib txwm tshwm sim dav hauv cov ntaub so ntswg xws li ntshav, nqaij, thiab tawv nqaij, thiab tuaj yeem tau txais los ntawm cov txheej txheem hluavtaws. Piv nrog rau thymosin β4, TB-500 khaws cov kev ua haujlwm lom neeg tseem ceeb thaum nws nkag tau yooj yim dua los ntawm cov ntaub so ntswg los ntawm kev txhaj tshuaj. Nws ua haujlwm yam tsis tas yuav muaj kev hloov kho nyuaj, ua rau nws yog ib qho ntawm feem ntau kawm peptide molecules hauv kev kho cov ntaub so ntswg.
TB-500 txhawb nqa cell migration thiab cov ntaub so ntswg regeneration los ntawm activating lub migratory muaj peev xwm ntawm kho cov hlwb xws li endothelial hlwb thiab fibroblasts. Nws accelerates angiogenesis thiab collagen deposition, pab nyob rau hauv kev kho ntawm connective cov ntaub so ntswg raug mob nyob rau hauv cov leeg, leeg, ligaments, thiab daim tawv nqaij. Nyob rau tib lub sijhawm, nws tswj hwm extracellular matrix tshuav nyiaj li cas kom txo qis qhov caws pliav ntau dhau. Nws nthuav tawm cov tshuaj tiv thaiv kab mob thiab cytoprotective los ntawm inhibiting qhov kev tso tawm ntawm pro-inflammatory yam xws li TNF-α thiab IL-1β, yog li txo cov nqaij o thiab edema. Tsis tas li ntawd, nws txhim kho cellular antioxidant kev ntxhov siab, txo kev puas tsuaj los ntawm ischemia thiab toxins, thiab ua lub luag haujlwm tseem ceeb hauv kev ruaj khov microenvironment ntawm cov ntaub so ntswg raug mob.
Nws yog siv los ua ib qho kev kho mob ntxiv rau kev ua kis las kis las xws li cov leeg nqaij, tendinitis, thiab ligament kua muag, ua kom lub voj voog kho kom zoo thiab pab txhawb kev rov ua haujlwm ntawm kis las. Hauv kev kho qhov txhab, nws ua kom nrawm kaw cov qhov txhab tsis zoo (piv txwv li, mob ntshav qab zib ko taw ulcers) thiab kub hnyiab raug mob los ntawm kev txhawb nqa granulation cov ntaub so ntswg loj hlob thiab epithelial cell migration. Hauv kev cuam tshuam cov ntaub so ntswg puas tsuaj, nws kuj qhia tau tias muaj txiaj ntsig zoo hauv cov hlab ntsha raug mob (piv txwv li, peripheral paj contusion) thiab kev tshawb fawb tom qab myocardial ischemia.
Xaus
BPC-157 / TB-500 Blend yog ib qho kev sib xyaw ua ke uas muaj ob lub peptides endogenous nrog cov haujlwm kho cov ntaub so ntswg. BPC-157, muab los ntawm tib neeg lub plab mucosal protein, muaj 15 amino acids, thaum TB-500 yog ib feem ntawm thymosin β4, muaj 43 amino acids. Thaum sib xyaw ua ke, lawv ua kom muaj kev sib koom ua ke. BPC-157 txhawb nqa fibroblast proliferation, txhim khu mucosal barrier kev ncaj ncees, thiab suppresses pro-inflammatory factor tso tawm, thaum TB-500 tswj actin polymerization, accelerates cell migration, thiab stimulates angiogenesis. Ua ke, lawv txhim kho cov ntaub so ntswg rov tsim dua tshiab thiab kho kev ua haujlwm zoo, nrog ntxiv cov tshuaj tiv thaiv kab mob, tiv thaiv kab mob hauv nruab nrog cev, thiab txhim kho cov cellular microenvironment. Kev tshawb fawb daim ntawv thov tam sim no tsom rau kev ua kis las raug mob (xws li, tendinitis, mob leeg, mob ligament); gastrointestinal mucosal tiv thaiv (piv txwv li, gastric ulcer, inflammatory plob tsis so tswj kab mob adjunctive intervention); thiab ntau cov ntaub so ntswg puas synergistic restoration (xws li, daim tawv nqaij qhov txhab, me visceral raug mob). Cov txheej txheem ntxiv no txo qis kev kho cov voj voog, txo cov lus teb inflammatory, thiab pab txhawb kev cuam tshuam hauv cov ntaub so ntswg puas tsuaj.
Hais Txog Tus Sau
Cov ntaub ntawv hais saum toj no yog txhua yam tshawb fawb, kho thiab sau los ntawm Cocer Peptides.
Tag nrho cov kab lus thiab cov ntaub ntawv ntawm cov khoom lag luam muab rau ntawm lub vev xaib no tsuas yog rau cov ntaub ntawv tshaj tawm kev tshaj tawm thiab cov hom phiaj kev kawm.
Cov khoom muab rau hauv lub vev xaib no yog npaj tshwj xeeb rau kev tshawb fawb hauv vitro. Kev tshawb fawb hauv vitro (Latin: * hauv iav *, lub ntsiab lus hauv iav) yog ua los ntawm tib neeg lub cev. Cov khoom no tsis yog tshuaj, tsis tau txais kev pom zoo los ntawm US Food and Drug Administration (FDA), thiab yuav tsum tsis txhob siv los tiv thaiv, kho, lossis kho txhua yam mob, kab mob, lossis mob. Nws raug txwv nruj raws li txoj cai los qhia cov khoom no rau hauv tib neeg lossis tsiaj lub cev hauv txhua daim ntawv.
